Publikationen in Zusammenarbeit mit Forschern von Policlinico S.Orsola-Malpighi (6)

2024

  1. ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options

    Annals of Hematology, Vol. 103, Núm. 7, pp. 2299-2310

2022

  1. Breakthrough infections in MPN-COVID vaccinated patients

    Blood Cancer Journal

  2. Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19

    American Journal of Hematology

  3. Second versus first wave of COVID-19 in patients with MPN

    Leukemia

2017

  1. Nilotinib first-line therapy in patients with Philadelphia chromosome-negative/BCR-ABL-positive chronic myeloid leukemia in chronic phase: ENEST1st sub-analysis

    Journal of Cancer Research and Clinical Oncology, Vol. 143, Núm. 7, pp. 1225-1233

2016

  1. European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia

    Leukemia, Vol. 30, Núm. 8, pp. 1648-1671